Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 5:01 AM
Ignite Modification Date:
2025-12-25 @ 5:01 AM
NCT ID:
NCT04354818
Eligibility Criteria:
Inclusion Criteria:
1. Presenting (in person or via telemedicine) for evaluation because they:
* Have clinical symptoms consistent with for COVID-19:
* Fever (≥ 37.8 °C) on examination OR patient reported fever (≥ 37.8 °C) or feverishness (felt febrile but did not take temperature) OR any of, cough, sore throat, shortness of breath, rhinorrhoea, headache, chills, generalise myalgia, malaise, fatigue, confusion, diarrhea, nausea or vomiting
* Have been contacted because they have been identified as a contact to a confirmed case
* Have been contacted and told they tested positive for COVID-19
2. Have one of the following conditions affecting immune function:
* Known or suspected primary immunodeficiency, defined as a predisposition to infection associated with an apparent or presumed deficit of immune function
* On immunosuppressive therapy
* Treatment with immune checkpoint inhibitors within 36 months of enrolment date
* HIV infection
* Diagnosis of cancer within 36 months of enrolment date, excluding superficial basal cell and squamous cell carcinomas
* Solid organ transplantation
3. For optional biobanking only, ability to provide informed consent
Exclusion Criteria:
* Nil
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04354818
Study Brief:
Protocol Section:
NCT04354818